期刊文献+

江苏省艾滋病患者未接受抗病毒治疗原因调查 被引量:10

A survey on the causation of the AIDS patients who declared eligible for highly active antiretroviral therapy not received treatment in Jiangsu province
下载PDF
导出
摘要 目的了解江苏省艾滋病患者未接受抗病毒治疗原因,并进一步扩大艾滋病免费抗病毒治疗覆盖面。方法调查江苏省截止2012年6月30日尚存活符合抗病毒治疗标准而未接受抗病毒治疗的艾滋病患者,调查日期为2012年7月1日~7月30日,建立Excel数据库并用SPSS 16.0统计软件分析。结果共调查544例患者,截止7月30日调查结束,其中188例已治疗,356例未治疗。356例患者未治疗的主要原因是药品还在申请中,其中有6例在调查时已死亡。符合治疗条件时的CD4+T 细胞水平越高,越不容易接受抗病毒治疗。结论江苏省应继续坚持艾滋病病毒感染者的早发现,缩短抗病毒药品供应周期,加强医师的培训。 Objective To analyze why the patients declared eligible for highly active antiretroviral therapy ( HAART) did not receive treatment, and increase treatment coverage. Methods According to the data of patients who declared eligible for HAART but not received treatment in the national epidemiology database till 2012/06/30 , Excelldatabase was established and statistical analysis was performed by using SPSS 16. 0 software. Results There were 544 patients who declared eligible for HAART but not received treatment by 2012/06/30,and actually only 356 were untreated by 2012/07/30 . The main causation of the 356 patients not receiving treatment was they were waiting for the free drugs,and 6 died before our survey. The subjects with higher CD4 +T cell count were apt to not receive HAART. Conclusion Earlier detection of AIDS patients and more education for doctors should be strengthened. Free drugs supply time should also be shortened.
出处 《安徽医科大学学报》 CAS 北大核心 2014年第3期319-322,共4页 Acta Universitatis Medicinalis Anhui
基金 江苏省医学重点人才项目(编号:RC2011083 RC2011086 RC2011087)
关键词 高效抗逆转录病毒治疗 艾滋病 未治疗原因 highly active antiretroviral therapy AIDS causation of not receiving HAART
  • 相关文献

参考文献3

二级参考文献30

  • 1张福杰,文毅,于兰,马烨,潘捷,赵燕.艾滋病的抗病毒治疗与我国的免费治疗现状[J].科技导报,2005,23(7):24-29. 被引量:104
  • 2陈谐捷,唐小平.艾滋病高效抗逆转录病毒治疗[J].中华全科医师杂志,2006,5(11):659-661. 被引量:17
  • 3姚璇,詹发先,彭国平.湖北省艾滋病抗病毒治疗终止原因分析[J].中国艾滋病性病,2006,12(6):495-497. 被引量:27
  • 4张福杰.国家免费艾滋病抗病毒药物治疗手册[M].2版.北京:人民卫生出版社,2008:25-34.
  • 5中华人民共和国卫生部,联合国艾滋病规划署.我国艾滋病防治工作取得显著成效[EB/OL].http//www.moh.gov.cn.
  • 6The strategies for management of antiretroviral therapy (SMART) study group. CD4~ count guided interruption of antiretroviral treatment [J].N Engl J Med,2006,355 (22) :2283-2296.
  • 7May M, Sterne JA, Sabin C, et al. The antiretroviral therapy(ART) cohort collaboration, prognosis of HIV-1-infected patients up to 5 years after initiation of HAART:collaborative analysis of prospective studies [J]. AIDS,2007,21 (9):1185-1197.
  • 8Kitahata MM, Gange S J, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival [J]. N Engl J Med,2009,360(18) : 1815-1826.
  • 9Gallant JE. When to start antiretroviral therapy? NA-AC- CORD stimulates the debate [J].AIDS Read,2009,19 (2) :49-50,61.
  • 10Freedberg KA,Losina E,Weinstein MC,et al. The cost effectiveness of combination antiretroviral therapy for HIV disease [ J ]. N Engl J Med, 2001,344 ( 11 ) : 824-831.

共引文献52

同被引文献74

引证文献10

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部